Lakefront Biotherapeutics (LKFT) Divestments (2021 - 2026)
Lakefront Biotherapeutics (LKFT) posted quarterly Divestments of $2.7 million for Q1 2026, down 91.83% year-over-year from $33.6 million in Q1 2025, and up 45.28% quarter-over-quarter from $1.9 million in Q4 2025.
Lakefront Biotherapeutics (LKFT) Divestments (2021 - 2026) Analysis & Trends
Lakefront Biotherapeutics (LKFT) has reported Divestments for 6 consecutive years, with $2.7 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Divestments fell 91.83% year-over-year to $2.7 million; the TTM figure through Mar 2026 stood at -$11.0 million (down 143.72% YoY), while the FY2025 annual figure was $22.6 million, up 336.52% from the prior year.
- Divestments advanced to $2.7 million in Q1 2026 per LKFT's latest filing, from $1.9 million in the prior quarter.
- Across five years, Divestments topped out at $33.6 million in Q1 2025 and bottomed at -$1.0 billion in Q1 2022.
- Historically, Divestments has averaged -$122.2 million across 5 years, with a median of -$1.5 million in 2024.
- Annual changes were most pronounced in 2022 — Divestments sank 3126.65% — and 2025, when it jumped 2408.57%.
- Lakefront Biotherapeutics' Divestments stood at -$1.0 billion in 2022, then soared by 70.43% to -$309.8 million in 2023, then soared by 100.43% to $1.3 million in 2024, then surged by 40.23% to $1.9 million in 2025, then surged by 45.28% to $2.7 million in 2026.
- Business Quant data shows LKFT's Divestments at $2.7 million in Q1 2026, $1.9 million in Q4 2025, and $9.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Divestments (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 9.82 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | -13.21 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Lakefront Biotherapeutics | 1.81 Bn | -1.68 Bn | 1.97 Mn | 2.74 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.74 Mn |
| Dec 31, 2025 | 1.89 Mn |
| Sep 30, 2025 | 9.44 Mn |
| Jun 30, 2025 | -25.12 Mn |
| Mar 31, 2025 | 33.58 Mn |
| Dec 31, 2024 | 1.35 Mn |
| Sep 30, 2024 | -5.49 Mn |
| Jun 30, 2024 | -4.17 Mn |
| Mar 31, 2024 | -1.45 Mn |
| Mar 31, 2023 | -309.84 Mn |
| Mar 31, 2022 | -1.05 Bn |
| Mar 31, 2021 | 34.61 Mn |